|
Re: REPROGRAM - trial with RVX208.
|
4
|
Resverlogix Corp.
|
Jul 13, 2020 06:34PM
|
|
Re: I'm Bullish Again on RVX and ZENITH
|
4
|
Zenith Epigenetics
|
Apr 21, 2016 03:47PM
|
|
Re: No answer yet on what the change in study protocol is....
|
4
|
Resverlogix Corp.
|
Jul 28, 2017 12:28PM
|
|
Re: 600 patients....doing the math
|
4
|
Resverlogix Corp.
|
Aug 30, 2016 10:33AM
|
|
Re: PNH Trial?
|
4
|
Resverlogix Corp.
|
Jul 05, 2017 08:12PM
|
|
Re: Their finest hour
|
4
|
Resverlogix Corp.
|
Sep 24, 2019 01:45PM
|
|
Re: Just Another Conference?
|
4
|
Resverlogix Corp.
|
Aug 28, 2016 08:57PM
|
|
Re: Dr. Kausik Ray will deliver the AHA Late Breaking Presentation on BETonMACE
|
4
|
Resverlogix Corp.
|
Nov 03, 2019 01:47PM
|
|
Re: A New Hope, Dementia
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 08:55PM
|
|
Victoza joins Jardiance as effective for reducing MACE in diabetics
|
4
|
Resverlogix Corp.
|
Mar 04, 2016 04:30PM
|
|
Re: NYAS Symposium on Apr 28
|
4
|
Resverlogix Corp.
|
Apr 21, 2016 03:52PM
|
|
Re: Unlimited variables in trial execution
|
4
|
Resverlogix Corp.
|
Jul 09, 2019 09:34AM
|
|
Re: ESPR results
|
4
|
Resverlogix Corp.
|
Aug 27, 2018 09:49AM
|
|
Re: Classifying/taxonomy mCRPC patients
|
4
|
Zenith Epigenetics
|
Apr 21, 2019 07:56AM
|
|
Re: 2018
|
4
|
Resverlogix Corp.
|
Mar 04, 2016 04:38PM
|
|
Re: Wednesday 3/23/16
|
4
|
Resverlogix Corp.
|
Mar 18, 2016 03:22PM
|
|
Re: Interesting Trades / Volume .....
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 09:08PM
|
|
Re: Comments re AHA presentation
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 09:09PM
|
|
Re: Rebuys start at $2.28
|
4
|
Resverlogix Corp.
|
Aug 09, 2018 11:29PM
|
|
Re: Inverted Hammer
|
4
|
Resverlogix Corp.
|
Nov 15, 2018 01:04PM
|
